Rosuvastatin Calcium
Rank #71 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$264.9M
Total Cost
11,259,701
Total Claims
$264.9M
Total Cost
108,872
Prescribers
$24
Cost per Claim
3,423,731
Beneficiaries
28,962,212
30-Day Fills
$2,433
Avg Cost/Provider
103
Avg Claims/Provider
Share of Medicare Part D Spending
0.10%
of total Medicare Part D spending
$264.9M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $264.9M total
Top Prescribers of Rosuvastatin Calcium
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mohammad Chaudhry | Internal Medicine | Union City, NJ | 2,517 | $212K |
| 2 | Najmuddin Karimjee | Internal Medicine | Houston, TX | 3,098 | $108K |
| 3 | Michael Satchell | Family Practice | Albany, GA | 9,693 | $103K |
| 4 | Don Lee | Interventional Cardiology | Glendale, CA | 2,871 | $87K |
| 5 | Kelvin Mai | Internal Medicine | Santa Ana, CA | 2,883 | $83K |
| 6 | Mitchell Davis | Family Practice | Ada, OK | 547 | $82K |
| 7 | Dae Rheem | Gastroenterology | Los Angeles, CA | 3,404 | $81K |
| 8 | Rodolfo Munera | Internal Medicine | Clifton, NJ | 645 | $75K |
| 9 | Isaac Snapp | Physician Assistant | Darlington, SC | 90 | $74K |
| 10 | Trista Marshall | Physical Medicine and Rehabilitation | Macon, GA | 7,546 | $73K |
| 11 | Marcela Marani-Dicovskiy | Internal Medicine | Paterson, NJ | 742 | $73K |
| 12 | Connie Wilson | Emergency Medicine | Ada, OK | 486 | $69K |
| 13 | Carol Carter | Nurse Practitioner | Claremore, OK | 430 | $67K |
| 14 | Ricardo Rey | Internal Medicine | Clifton, NJ | 714 | $67K |
| 15 | Henry Yee | Cardiology | Alhambra, CA | 2,220 | $66K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 68 | Liraglutide (Victoza 3-Pak) | $273.0M | 189,358 |
| 69 | Elexacaftor/Tezacaftor/Ivacaft (Trikafta) | $269.3M | 9,821 |
| 70 | Immune Globul G/Gly/Iga Avg 46 (Gamunex-C) | $266.5M | 27,501 |
| 71 | Rosuvastatin Calcium (Rosuvastatin Calcium) | $264.9M | 11,259,701 |
| 72 | Risankizumab-Rzaa (Skyrizi Pen) | $259.7M | 12,539 |
| 73 | Venetoclax (Venclexta) | $259.6M | 28,191 |
| 74 | Zanubrutinib (Brukinsa) | $256.8M | 19,239 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology